Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine

Historical observation

20182026

Universe›Health Care›Pharmaceuticals›Pharmaceuticals

1 · Sector

Weight and 12M allocation change

Materials30.1%+27.83 pp Energy2.0%-0.58 pp Communication Services2.1%-0.59 pp Utilities2.1%-0.66 pp Real Estate1.6%-0.88 pp Industrials7.7%-1.89 pp Consumer Staples4.9%-2.28 pp Consumer Discretionary8.4%-3.45 pp Health Care8.2%-4.24 pp Financials7.7%-4.88 pp Information Technology25.3%-8.39 pp

2 · Industry

Inside Health Care

Health Care Equipment1.52%-1.15 pp Pharmaceuticals3.09%-1.07 pp Managed Health Care0.52%-0.79 pp Biotechnology1.47%-0.57 pp Life Sciences Tools & Services0.66%-0.42 pp Health Care Services0.32%-0.17 pp Health Care Supplies0.07%-0.04 pp Health Care Distributors0.35%-0.03 pp Health Care Technology0.02%-0.01 pp Health Care Facilities0.16%-0.01 pp

3 · Sub-industry

Inside Pharmaceuticals

Pharmaceuticals3.09%-1.066 pp

Concentrated

Most of this industry's losses came from a few companies.

View all contributions →

Pharmaceuticals · weight

3.09%

Industry change · 12M

-1.07 pp

Pharmaceuticals · contribution

-1.066 pp

Company participation

of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Feb 2026 · sorted by absolute contribution to 12-month change

Company	Country	Market cap	Universe weight	3M contribution	12M contribution	12M price return	Above 6M weight average
Lilly (Eli) → LLY	United States	$992.4bn	1.362%	-0.635 pp	-0.590 pp	+15.1%	No
Pfizer → PFE	United States	$157.2bn	0.216%	-0.072 pp	-0.119 pp	+12.2%	No
Merck & Co. → MRK	United States	$306.1bn	0.420%	-0.091 pp	-0.101 pp	+39.3%	No
Bristol Myers Squibb → BMY	United States	$127.0bn	0.174%	-0.022 pp	-0.096 pp	+9.9%	No
Zoetis → ZTS	United States	$55.3bn	0.076%	-0.035 pp	-0.092 pp	-20.5%	No
Johnson & Johnson → JNJ	United States	$598.7bn	0.822%	-0.158 pp	-0.067 pp	+54.7%	No
Viatris → VTRS	United States	$17.2bn	0.024%	-0.001 pp	-0.001 pp	+70.0%	No

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.